Forbion Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
36
- Investments
-
256
- Portfolio
-
68
- Exits
-
109
Forbion General Information
Company Description
Founded in 2000, Forbion is a venture capital firm based in Naarden, Netherlands. The firm prefers to invest in biotech, human health, and planetary health sectors.
Business Details
Website
www.forbion.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Corporate Office
- Gooimeer 2-35
- 1411 DC Naarden
- Netherlands
Forbion Investments & Acquisitions (256)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| VectorY Therapeutics | 11-Nov-2026 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 1 | ||
| OMass Therapeutics | 15-Oct-2026 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Marea | 17-Sep-2026 | Biotechnology | Clinical Trials - Phase 2 | |||
| Sling Therapeutics | 16-Sep-2026 | Drug Discovery | Clinical Trials - Phase 3 | |||
| CaMaRa | 09-Sep-2026 | Drug Discovery | Startup | |||
| Solstice Oncology | 09-Sep-2026 | Biotechnology | Clinical Trials - Phase 2 | |||
| Korsana Biosciences | 07-Sep-2026 | Drug Discovery | Pre-Clinical Trials | |||
| Kynexis | 19-Aug-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Slate Medicines | 17-Aug-2026 | PIPE | Biotechnology | Clinical Trials - Phase 1 | ||
| Expedition Therapeutics | 05-Aug-2026 | Early Stage VC | Biotechnology | Clinical Trials - Phase 2 |
Forbion Exits (109)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| AM-Pharma | 20-Oct-2026 | Merger/Acquisition | |
| Marea | 17-Sep-2026 | ||
| Braveheart Bio | 06-Aug-2026 | ||
| Crescent Biopharma | 16-Jul-2026 | ||
| Damora Therapeutics ( Drug Discovery) | 10-Feb-2026 | ||
| Precirix | 20-Jan-2026 | ||
| Rampart Bioscience | 09-Jan-2026 | ||
| Dualyx | 17-Nov-2025 | ||
| EnGene Therapeutics | 14-Nov-2025 | Public Investment 2nd Offering | |
| Vor Biopharma | 12-Nov-2025 | Public Investment 2nd Offering |
Forbion Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Forbion Investments by Industry, Year, and Region
Forbion Co-Investors (281)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| RA Capital Management | 15 |
|
|
||
| Novo Holdings |
|
|
|||
| Novartis Venture Fund |
|
|
|||
| BioGeneration Ventures |
|
|
|||
| Sofinnova Partners |
|
|
Forbion FAQs
-
What is Forbion?
Founded in 2000, Forbion is a venture capital firm based in Naarden, Netherlands.
-
When was Forbion founded?
Forbion was founded in 2000.
-
Where is Forbion headquartered?
Forbion is headquartered in Naarden, Netherlands.
-
What is Forbion's total asset value?
Forbion has around in total assets under management.
-
How many investments has Forbion made?
Forbion has made 256 investments.
-
What has Forbion invested in?
Forbion has made numerous investments in companies like VectorY Therapeutics, OMass Therapeutics, and Marea within the Drug Discovery and Biotechnology industries.
-
What has Forbion invested in recently?
Forbion's latest investment was on 11-Nov-2026 in VectorY Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process